Analysen von Michael Leuchten
| 19.01.17 | Novo Nordisk buy | UBS AG | |
| 15.12.16 | Bayer buy | UBS AG | |
| 06.12.16 | Bayer buy | UBS AG | |
| 06.12.16 | Novo Nordisk buy | UBS AG | |
| 12.05.16 | Sanofi overweight | Barclays Capital | |
| 04.05.16 | GSK overweight | Barclays Capital | |
| 02.05.16 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
|
Werbung
|
|||
| 15.01.16 | Roche overweight | Barclays Capital | |
| 08.01.16 | Novo Nordisk overweight | Barclays Capital | |
| 28.07.15 | Roche overweight | Barclays Capital | |
| 12.02.15 | Roche overweight | Barclays Capital | |
| 26.07.10 | Actelion overweight | Barclays Capital | |